Kamlesh Yadav
Understanding the biology of how prostate cancer cells develop resistance to drugs, and how different drugs interact with one another will lead to the development of drug combinations that significantly...Read More
Kathryn Wilson
Metastatic prostate cancer is essentially incurable and the most common metastatic site for prostate cancer is the bone. Understanding the interactions between prostate cancer cells and the bone environment will...Read More
Hannelore Heemers
Androgens (testosterone and related sex hormones) drive the growth and survival of prostate cancer. For almost seven decades, reducing androgens in patients with prostate cancer has been a widely utilized...Read More
Julia Hayes
Prostate Specific Antigen (PSA) screening is widely used to assist the early diagnosis of prostate cancer. However, benefits of PSA screening are controversial. Dr. Hayes proposes to develop a model...Read More
Daniel Hamstra
The molecular processes that predict who will have a local recurrence after radiation therapy and who will not are not precisely understood. New evidence suggests that prostate tumors with abnormal...Read More
Hans Hammers
Dr. Hammers has initiated a project to determine the mechanisms of resistance of advanced prostate cancer to angiogenesis inhibitors, like Avastin, that block the development of new blood vessels that...Read More
David S. Finley
Obesity increases the risk of developing prostate cancer and most major cancers. New data suggests that adipose tissue (body fat), now considered an “organ,” is capable of secreting numerous molecules...Read More
Robert Den
Radiation therapy in combination with medicines that block testosterone (hormonal therapy) is a common treatment for locally advanced prostate cancer. However, a subset of these patients will not be cured...Read More